119 related articles for article (PubMed ID: 36762595)
1. Development and validation of risk calculators for people with "thin" melanomas on their skin to predict the likelihood that their cancer will return: a plain language summary of publication.
Sharouni ME; Lo SN; Varey AH; Elias SG; Witkamp AJ; Sigurdsson V; Suijkerbuijk KP; van Diest PJ; van Gils CH; Blokx WA; Scolyer RA; Thompson JF
Future Oncol; 2023 Jan; 19(2):97-102. PubMed ID: 36762595
[TBL] [Abstract][Full Text] [Related]
2. Development and Validation of Nomograms to Predict Local, Regional, and Distant Recurrence in Patients With Thin (T1) Melanomas.
El Sharouni MA; Ahmed T; Varey AHR; Elias SG; Witkamp AJ; Sigurdsson V; Suijkerbuijk KPM; van Diest PJ; Scolyer RA; van Gils CH; Thompson JF; Blokx WAM; Lo SN
J Clin Oncol; 2021 Apr; 39(11):1243-1252. PubMed ID: 33600211
[TBL] [Abstract][Full Text] [Related]
3. Development and Assessment of a Clinical Calculator for Estimating the Likelihood of Recurrence and Survival Among Patients With Locally Advanced Rectal Cancer Treated With Chemotherapy, Radiotherapy, and Surgery.
Weiser MR; Chou JF; Keshinro A; Chapman WC; Bauer PS; Mutch MG; Parikh PJ; Cercek A; Saltz LB; Gollub MJ; Romesser PB; Crane CH; Shia J; Markowitz AJ; Garcia-Aguilar J; Gönen M;
JAMA Netw Open; 2021 Nov; 4(11):e2133457. PubMed ID: 34748003
[TBL] [Abstract][Full Text] [Related]
4. A risk prediction model for the development of subsequent primary melanoma in a population-based cohort.
Cust AE; Badcock C; Smith J; Thomas NE; Haydu LE; Armstrong BK; Law MH; Thompson JF; Kanetsky PA; Begg CB; Shi Y; Kricker A; Orlow I; Sharma A; Yoo S; Leong SF; Berwick M; Ollila DW; Lo S
Br J Dermatol; 2020 May; 182(5):1148-1157. PubMed ID: 31520533
[TBL] [Abstract][Full Text] [Related]
5. The interplay of sun damage and genetic risk in Australian multiple and single primary melanoma cases and controls.
McMeniman EK; Duffy DL; Jagirdar K; Lee KJ; Peach E; McInerney-Leo AM; De'Ambrosis B; Rayner JE; Smithers BM; Soyer HP; Sturm RA
Br J Dermatol; 2020 Aug; 183(2):357-366. PubMed ID: 31794051
[TBL] [Abstract][Full Text] [Related]
6. Increasing time trends of thin melanomas in The Netherlands: What are the explanations of recent accelerations?
van der Leest RJ; Zoutendijk J; Nijsten T; Mooi WJ; van der Rhee JI; de Vries E; Hollestein LM
Eur J Cancer; 2015 Dec; 51(18):2833-41. PubMed ID: 26589973
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of the transferability of survival calculators for stage II/III colon cancer across healthcare systems.
Jorissen RN; Croxford M; Jones IT; Ward RL; Hawkins NJ; Gibbs P; Sieber OM
Int J Cancer; 2019 Jul; 145(1):132-142. PubMed ID: 30620048
[TBL] [Abstract][Full Text] [Related]
8. The effect of screening on melanoma incidence and biopsy rates.
Whiteman DC; Olsen CM; MacGregor S; Law MH; Thompson B; Dusingize JC; Green AC; Neale RE; Pandeya N;
Br J Dermatol; 2022 Oct; 187(4):515-522. PubMed ID: 35531668
[TBL] [Abstract][Full Text] [Related]
9. Predicting sentinel node positivity in patients with melanoma: external validation of a risk-prediction calculator (the Melanoma Institute Australia nomogram) using a large European population-based patient cohort.
El Sharouni MA; Varey AHR; Witkamp AJ; Ahmed T; Sigurdsson V; van Diest PJ; Scolyer RA; Thompson JF; Lo SN; van Gils CH
Br J Dermatol; 2021 Aug; 185(2):412-418. PubMed ID: 33657653
[TBL] [Abstract][Full Text] [Related]
10. Prognostication in thin cutaneous melanomas.
Gimotty PA; Guerry D
Arch Pathol Lab Med; 2010 Dec; 134(12):1758-63. PubMed ID: 21128772
[TBL] [Abstract][Full Text] [Related]
11. A nomogram to predict node positivity in patients with thin melanomas helps inform shared patient decision making.
Friedman C; Lyon M; Torphy RJ; Thieu D; Hosokawa P; Gonzalez R; Lewis KD; Medina TM; Rioth MJ; Robinson WA; Kounalakis N; McCarter MD; Gleisner AL
J Surg Oncol; 2019 Dec; 120(7):1276-1283. PubMed ID: 31602665
[TBL] [Abstract][Full Text] [Related]
12. Optimal surveillance strategies for patients with stage 1 cutaneous melanoma post primary tumour excision: three systematic reviews and an economic model.
Vale L; Kunonga P; Coughlan D; Kontogiannis V; Astin M; Beyer F; Richmond C; Wilson D; Bajwa D; Javanbakht M; Bryant A; Akor W; Craig D; Lovat P; Labus M; Nasr B; Cunliffe T; Hinde H; Shawgi M; Saleh D; Royle P; Steward P; Lucas R; Ellis R
Health Technol Assess; 2021 Nov; 25(64):1-178. PubMed ID: 34792018
[TBL] [Abstract][Full Text] [Related]
13. Efficiency of Detecting New Primary Melanoma Among Individuals Treated in a High-risk Clinic for Skin Surveillance.
Guitera P; Menzies SW; Coates E; Azzi A; Fernandez-Penas P; Lilleyman A; Badcock C; Schmid H; Watts CG; Collgros H; Liu R; van Kemenade C; Mann GJ; Cust AE
JAMA Dermatol; 2021 May; 157(5):521-530. PubMed ID: 33729464
[TBL] [Abstract][Full Text] [Related]
14. Smartphone applications for triaging adults with skin lesions that are suspicious for melanoma.
Chuchu N; Takwoingi Y; Dinnes J; Matin RN; Bassett O; Moreau JF; Bayliss SE; Davenport C; Godfrey K; O'Connell S; Jain A; Walter FM; Deeks JJ; Williams HC;
Cochrane Database Syst Rev; 2018 Dec; 12(12):CD013192. PubMed ID: 30521685
[TBL] [Abstract][Full Text] [Related]
15. Time trends and latitudinal differences in melanoma thickness distribution in Australia, 1990-2006.
Baade P; Meng X; Youlden D; Aitken J; Youl P
Int J Cancer; 2012 Jan; 130(1):170-8. PubMed ID: 21344376
[TBL] [Abstract][Full Text] [Related]
16. Development and validation of prognostic nomogram in patients with nonmetastatic malignant melanoma: a SEER population-based study.
Xiao Y; Peng S; Hu Y; Zhang J; Cao X
Cancer Med; 2020 Nov; 9(22):8562-8570. PubMed ID: 32941704
[TBL] [Abstract][Full Text] [Related]
17. Follow-Up Recommendations after Diagnosis of Primary Cutaneous Melanoma: A Population-Based Study in New South Wales, Australia.
Read RL; Madronio CM; Cust AE; Goumas C; Watts CG; Menzies S; Curtin AM; Mann G; Thompson JF; Morton RL
Ann Surg Oncol; 2018 Mar; 25(3):617-625. PubMed ID: 29299710
[TBL] [Abstract][Full Text] [Related]
18. The management of primary cutaneous melanoma in Victoria in 1996 and 2000.
Kelly JW; Henderson MA; Thursfield VJ; Slavin J; Ainslie J; Giles GG
Med J Aust; 2007 Nov; 187(9):511-4. PubMed ID: 17979616
[TBL] [Abstract][Full Text] [Related]
19. Population-based 20-year survival among people diagnosed with thin melanomas in Queensland, Australia.
Green AC; Baade P; Coory M; Aitken JF; Smithers M
J Clin Oncol; 2012 May; 30(13):1462-7. PubMed ID: 22412152
[TBL] [Abstract][Full Text] [Related]
20. Clinicopathological factors associated with death from thin (≤ 1·00 mm) melanoma.
Claeson M; Baade P; Brown S; Soyer HP; Smithers BM; Green AC; Whiteman DC; Khosrotehrani K
Br J Dermatol; 2020 Apr; 182(4):927-931. PubMed ID: 31562769
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
